食欲症状在肝癌营养不良患者中的研究进展

doi:10.3969/j.issn.1000-8535.2024.06.002

广州医药 ›› 2024, Vol. 55 ›› Issue (6): 585-590.DOI: 10.3969/j.issn.1000-8535.2024.06.002

食欲症状在肝癌营养不良患者中的研究进展

郑春东¹, 龙丽珍², 黄秋环³, 唐强⁴, 王婷¹

1 右江民族医学院研究生学院（广西百色 533000）
2 右江民族医学院附属医院肝胆外科（广西百色 533000）
3 右江民族医学院附属医院护理部（广西百色 533000）
4 右江民族医学院附属医院百东医院医疗整形美容科（广西百色 533000）

收稿日期:2024-01-22 出版日期:2024-06-20 发布日期:2024-07-31
通讯作者: 龙丽珍,E-mail：longlizhen0828@163.com
基金资助:
国家自然科学基金项目（82160907）; 广西壮族自治区中医药管理局自筹经费科研课题（GXZYL20220305）; 广西壮族自治区卫生健康委西医类自筹经费科研课题（Z-L20230899）

Progress of appetite symptoms in malnourished patients with hepatocellular carcinoma

ZHENG Chundong¹, LONG Lizhen², HUANG Qiuhuan³, TANG Qiang⁴, WANG Ting¹

1 Graduate School of Youjiang Medical College of Nationalities,Baise 533000,China
2 Department of Hepatobiliary Surgery,Affiliated Hospital of Youjiang Medical College for Nationalities,Baise 533000,China
3 Department of Nursing,Affiliated Hospital of Youjiang Medical College for Nationalities,Baise 533000,China
4 Department of Plastic and Reconstructive Surgery,Baidong Hospital,Affiliated Hospital of Youjiang Medical College for Nationalities,Baise 533000,China

Received:2024-01-22 Online:2024-06-20 Published:2024-07-31

摘要/Abstract

摘要： 肝癌患者因食欲降低、进食减少导致不同程度的营养不良,引发厌食症,甚至恶病质,严重影响患者生存质量。食欲评估是降低营养风险的基础,医护人员可通过食欲症状的评估调整患者饮食及营养指导措施,以改善患者营养状态,提高生存质量。该文对食欲的评估工具、方法及干预在肝癌营养不良患者中的应用现状进行阐述,为肝癌患者的食欲干预提供科学依据。

关键词: 肝癌, 食欲症状, 营养不良, 进展

Abstract: Hepatocellular carcinoma patients suffer from different degrees of malnutrition due to decreased appetite and eating,which triggers anorexia and even cachexia,seriously affecting the quality of patient survival．Appetite assessment is the basis for reducing nutritional risk,and healthcare professionals can adjust patients’ diet and nutritional guidance measures through the assessment of appetite symptoms in order to improve patients’ nutritional status and survival quality．In this paper,the current status of the assessment tools,methods and interventions of appetite in malnutrition patients with hepatocellular carcinoma are described to provide a scientific basis for appetite interventions．

Key words: hepatocellular carcinoma, appetite symptoms, malnutrition, progression

郑春东, 龙丽珍, 黄秋环, 唐强, 王婷. 食欲症状在肝癌营养不良患者中的研究进展[J]. 广州医药, 2024, 55(6): 585-590.

ZHENG Chundong, LONG Lizhen, HUANG Qiuhuan, TANG Qiang, WANG Ting. Progress of appetite symptoms in malnourished patients with hepatocellular carcinoma[J]. Guangzhou Medical Journal, 2024, 55(6): 585-590.

参考文献

[1] MOORE H,WHITE M J,FINLAYSON G,et al.Can smartphone-based response inhibition training elicit sustained changes in appetite,preference,and cravings for energy-dense foods?A free-living randomized controlled trial[J].Br J Health Psychol,2024,29(1):165-184.
[2] HARIYANTO T I,KURNIAWAN A.Appetite problem in cancer patients:Pathophysiology,diagnosis,and treatment[J].Cancer Treat Res Commun,2021(27):100336.
[3] MUSCARITOLI M,ARENDS J,BACHMANN P,et al.ESPEN practical guideline:Clinical nutrition in cancer[J].Clin Nutr,2021,40(5):2898-2913.
[4] KAPLAN A,ROSENBLATT R.Symptom management in patients with cirrhosis:A practical guide[J].Curr Treat Options Gastroenterol,2022,20(2):144-159.
[5] UKOVIC B,PORTER J.Nutrition interventions to improve the appetite of adults undergoing cancer treatment:A systematic review[J].Support Care Cancer,2020,28(10):4575-4583.
[6] DEVARBHAVI H,ASRANI S K,ARAB J P,et al.Global burden of liver disease:2023 update[J].J Hepatol,2023,79(2):516-537.
[7] ZELLI V,COMPAGNONI C,CAPELLI R,et al.Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms:Focus on hepatocellular carcinoma[J].Front Oncol,2022(12):940056.
[8] Sung H,Ferlay J,Siegel R L,et al.Global Cancer Statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[9] 方亮,熊晓云,方路,等.基于ESPEN标准探讨四种营养筛查工具对肝细胞肝癌患者的营养评估及预后价值[J].实用医学杂志,2020,36(20):2792-2796,2801.
[10] 宋春花,王昆华,郭增清,等.中国常见恶性肿瘤患者营养状况调查[J].中国科学:生命科学,2020,50(12):1437-1452.
[11] 陈墅圳,蒋文燕,刘杰.基于倾向性评分匹配分析系统免疫炎症指数对早、中期肝细胞癌术后早期复发的预测价值[J].广州医药,2023,54(10):83-89.
[12] XIE H,TIAN S,CUI L,et al.Adjuvant trans-arterial chemoembolization after hepatectomy significantly improves the prognosis of low-risk patients with R0-stage hepatocellular carcinoma[J]. Cancer Manag Res,2019(11):4065-4073.
[13] 孟杨,侯婧悦,李洁,等.动态营养支持对原发性肝癌术后免疫功能及炎症应激反应的影响[J].现代消化及介入诊疗,2022,27(12):1578-1582.
[14] 王瑛,袁鹤立,赵利,等.伴营养不良风险的原发性肝癌患者临床特征及预后因素分析[J].中西医结合肝病杂志,2022,32(6):494-498.
[15] KIM Y,KIM S R,KIM K,et al.Demographic,clinical and psychological predictors of malnutrition among people with liver cancer[J].Eur J Oncol Nurs,2023(68):102497.
[16] RICH N E,PHEN S,DESAI N,et al.Cachexia is Prevalent in patients with hepatocellular carcinoma and associated with worse prognosis[J].Clin Gastroenterol Hepatol,2022,20(5):e1157-e1169.
[17] BAAZIM H,ANTONIO-HERRERA L,BERGTHALER A.The interplay of immunology and cachexia in infection and cancer[J].Nat Rev Immunol,2022,22(5):309-321.
[18] LUO J,GAO B,LIN Z,et al.Efficacy and safety of lenvatinib versus sorafenib in first-line treatment of advanced hepatocellular carcinoma:A meta-analysis[J].Front Oncol,2022(12):1010726.
[19] TIAN T,GUO J,HU J L,et al.Advanced hepatocellular carcinoma and palliative care:A scoping review[J].BMJ Support Palliat Care,2024,14(2):163-170.
[20] ISHIZU Y,ISHIGAMI M,HONDA T,et al.Decreased appetite is associated with the presence of sarcopenia in patients with cirrhosis[J].Nutrition,2022(103-104):111807.
[21] 胡豆. 基于患者报告结局的肝癌患者围术期症状群与生活质量相关性的纵向研究[D].成都:电子科技大学,2023.
[22] 胡雁. 症状科学的发展及研究趋势[J].护士进修杂志,2023,38(24):2209-2213.
[23] 王琪,吕利明,薄纯圆,等.肿瘤患者癌性厌食评估与干预的最佳证据总结[J].护理学杂志,2023,38(23):25-29.
[24] WAGNER M,PROBST P,HASELBECK-KÖBLER M,et al.The problem of appetite loss after major abdominal surgery:A systematic review[J].Ann Surg,2022,276(2):256-269.
[25] 杨如卉. 肝癌切除术后患者症状自我管理体验、自我管理现状及影响因素分析[D].新乡:新乡医学院,2022.
[26] 李杰,常金圆,陈佳阳,等.基于“运中调衡”法辨治肿瘤患者食欲减退[J].国际中医中药杂志,2023,45(6):780-783.
[27] 靳飘洋,薛敬东,李婕.中医联合介入治疗原发性肝癌的研究进展[J].中西医结合肝病杂志,2023,33(9):857-860.
[28] 彭莉,王若宇,陈舒婷,等.吴茱萸穴位贴敷改善肝癌不同介入治疗所致胃肠道反应的护理研究[J].中医药导报,2023,29(4):98-103.
[29] 吴叶琪,王睿.耳穴治疗肿瘤相关食欲减退的临床运用规律研究进展[J].中国中医药科技,2022,29(6):1132-1135.
[30] 刘石红. 健脾益气法治疗癌症术后食欲不振临床观察[J].光明中医,2023,38(17):3360-3362.
[31] 段彤. 皮内针疗法治疗癌性厌食症的临床疗效观察[D].长沙:湖南中医药大学,2023.
[32] ZHU Y,BLUNDELL J E,HOLSCHUH N M,et al.Validation of a mobile app-based visual analog scale for appetite measurement in the real world:A randomized digital clinical trial[J].Nutrients,2023,15(2):304.
[33] 中国抗癌协会肿瘤营养专业委员会,全国卫生产业企业管理协会医学营养产业分会,浙江省医学会肿瘤营养与治疗学分会.肿瘤患者食欲下降的营养诊疗专家共识[J].肿瘤代谢与营养电子杂志,2022,9(3):312-319.
[34] 李增宁,李晓玲,陈伟,等.肿瘤患者食欲评价和调节的专家共识[J].肿瘤代谢与营养电子杂志,2020,7(2):169-177.
[35] European Association for the Study of the Liver.EASL Clinical Practice Guidelines on nutrition in chronic liver disease[J].J Hepatol,2019,70(1):172-193.
[36] VERMA M,KALMAN R,HORROW J,et al.Feasibility of a palliative care intervention within routine care of hepatocellular carcinoma:A pilot randomized controlled trial[J].J Palliat Med,2023,26(3):334-341.
[37] CHEN R,YANG S,XU Z,et al.Validation and application of the Chinese version of the M.D.Anderson Symptom Inventory Gastrointestinal Cancer Module(MDASI-GI-C)[J].J Pain Symptom Manage,2019,57(4):820-827.
[38] XU L,WANG S,ZHUANG L,et al.Jian pi li qi decoction alleviated postembolization syndrome following transcatheter arterial chemoembolization for hepatocellular carcinoma:A randomized,double-blind,placebo-controlled trial[J].Integr Cancer Ther,2016,15(3):349-357.
[39] 黄子寅,培尔顿·米吉提,凯比努尔·艾尔肯.EORTC QLQ-C30量表汇总评分在中国结直肠癌患者中的验证[J].中华肿瘤防治杂志,2022,29(16):1171-1176.
[40] 唐明尧,黄微,陈媛,等.认知干预对接受射频治疗的肝细胞癌患者生活质量及负性情绪的影响[J].现代肿瘤医学,2020,28(23):4115-4119.
[41] 张晓轩,龙顺钦,杨小兵,等.健脾理气抑瘤方联合CIK治疗对晚期肝细胞癌患者免疫功能及生活质量的影响[J].广东医学,2016,37(3):441-444.
[42] BISCHOFF S C,BERNAL W,DASARATHY S,et al.ESPEN practical guideline:Clinical nutrition in liver disease[J].Clin Nutr,2020,39(12):3533-3562.
[43] 吴梅,顾丽丽,杨艳,等.基于授权理论的干预模式在肝癌术后患者护理中的应用[J].临床与病理杂志,2023,43(5):1011-1018.
[44] PALMESE F,BOLONDI I,GIANNONE F A,et al.The analysis of food intake in patients with cirrhosis waiting for liver transplantation:A neglected step in the nutritional assessment[J].Nutrients,2019,11(10):2462.
[45] CASAS DEZA D,BETORÉ GLARIA M E,SANZ PARÍS A,et al.Mini nutritional assessment ‐ short form is a useful malnutrition screening tool in patients with liver cirrhosis,using the global leadership initiative for malnutrition criteria as the gold standard[J].Nut Clin Prac,2021,36(5):1003-1010.

食欲症状在肝癌营养不良患者中的研究进展

Progress of appetite symptoms in malnourished patients with hepatocellular carcinoma

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	李儒雅, 梁亮, 周睿卿, 郝嘉懿, 阎文锦, 黄金棋, 王顺清. 血友病基因治疗国内外研究新进展[J]. 广州医药, 2024, 55(4): 331-341.
[2]	陈喻萍, 卢茜, 杨磊, 曾丽娟. 慢性阻塞性肺疾病患者吞咽障碍评估工具的研究进展[J]. 广州医药, 2023, 54(6): 106-111.
[3]	聂韵, 邓浩荣, 梁巧菊, 杨杰文. 脑性瘫痪伴营养不良患儿进行系统性饮食调整的效果观察[J]. 广州医药, 2023, 54(12): 78-82.
[4]	崔静, 张智玲. 医用几丁糖治疗不可复性关节盘前移位患者临床疗效及生活质量分析[J]. 广州医药, 2023, 54(11): 59-64.
[5]	段志文, 聂丹丹, 兰婷. 癫痫患者疾病进展恐惧水平及其相关影响因素分析[J]. 广州医药, 2023, 54(11): 91-94.
[6]	陈墅圳, 蒋文燕, 刘杰. 基于倾向性评分匹配分析系统免疫炎症指数对早、中期肝细胞癌术后早期复发的预测价值[J]. 广州医药, 2023, 54(10): 83-89.
[7]	吴勇, 况钦, 周梦瑶, 杜彬, 毋楠, 冯涛. SNHG12在乙肝病毒X蛋白诱导肝癌发生中的作用研究[J]. 广州医药, 2023, 54(1): 16-24.
[8]	郭小芳, 王凌云, 吕天宝. CT扫描结合磁共振在原发性肝癌诊断与介入治疗预后评估中的临床意义[J]. 广州医药, 2022, 53(3): 38-41.
[9]	庄薇, 钟宁. 组蛋白去乙酰化酶抑制剂对肝癌诱导自噬的作用[J]. 广州医药, 2022, 53(2): 39-43.
[10]	郭小芳, 王凌云, 吕天宝. CT扫描结合MRI在原发性肝癌诊断与介入治疗预后评估中的临床意义[J]. 广州医药, 2022, 53(1): 58-61.
[11]	张林洋, 朱玲玲, 朱国华. 中医药治疗前列腺癌研究进展[J]. 广州医药, 2021, 52(5): 135-138.
[12]	胡志文, 萧淑宜, 格桑卓玛, 金海, 董燕, 柳建华. 微泡超声空化在增强微波消融对肝脏肿瘤的热消融效应中的价值[J]. 广州医药, 2021, 52(1): 43-48.
[13]	李柱, 廖信芳, 吕海钠. 超声引导下射频消融术治疗肝癌术后局部复发因素分析[J]. 广州医药, 2020, 51(6): 79-82.
[14]	张惠丽, 成秋生, 陈希, 李泽. 一个以心脏损害为首发症状的杜氏肌营养不良症家系的遗传学及临床研究[J]. 广州医药, 2020, 51(3): 36-41.
[15]	林晓纯, 林坤鹏, 林纯旋. 贝伐单抗联合肝动脉化疗栓塞治疗原发性肝癌的 Meta分析[J]. 广州医药, 2020, 51(3): 86-92.